HealthLynked (HLYK) Net Income towards Common Stockholders (2016 - 2026)

HealthLynked has disclosed Net Income towards Common Stockholders across 11 years of filings, most recently posting -$1.7 million for Q1 2026.

• In Q1 2026, Net Income towards Common Stockholders fell 57.73% year-over-year to -$1.7 million; the TTM figure through Mar 2026 stood at -$3.2 million (up 30.7% YoY), while the FY2025 annual figure was -$2.1 million, up 54.82% from the prior year.
• Net Income towards Common Stockholders declined to -$1.7 million in Q1 2026, from -$530894.0 in the prior quarter.
• Over the last five years, Net Income towards Common Stockholders for HLYK reached as high as $1.5 million in Q1 2023 and fell as low as -$4.4 million in Q4 2022.
• The 5-year median for Net Income towards Common Stockholders is -$1.1 million (2024), against an average of -$1.1 million.
• Annual changes were most pronounced in 2023 — Net Income towards Common Stockholders surged 215.55% — and 2024, when it plunged 855.47%.
• A 5-year view of Net Income towards Common Stockholders shows it stood at -$4.4 million in 2022, then jumped by 70.53% to -$1.3 million in 2023, then surged by 41.76% to -$748774.0 in 2024, then climbed by 29.1% to -$530894.0 in 2025, then plunged by 212.24% to -$1.7 million in 2026.
• According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered -$1.7 million, -$530894.0, and -$529586.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.